APLT INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Class Action Lawsuit Overview - The law firm Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Applied Therapeutics Inc (NASDAQ: APLT) for securities purchased or acquired between January 3 2024 and December 2 2024 [1] - The lawsuit alleges violations of the Securities Exchange Act of 1934 by Applied Therapeutics and certain top executives [1] - Investors who suffered substantial losses can seek appointment as lead plaintiff by February 18 2025 [1] Case Allegations - Applied Therapeutics is a clinical-stage biopharmaceutical company developing drug candidates for rare diseases [2] - The company submitted a New Drug Application (NDA) to the FDA for govorestat to treat Classic Galactosemia on January 3 2024 [2] - The lawsuit claims that Applied Therapeutics made false or misleading statements and failed to disclose non-adherence to trial protocols and good clinical practices, risking FDA rejection of trial data [3] FDA Response and Stock Impact - On November 27 2024, the FDA issued a Complete Response Letter for the NDA, stating it could not approve the application in its current form due to deficiencies in the clinical application [4] - Following this news, Applied Therapeutics stock price fell more than 80% over three trading sessions [4] - On December 2 2024, the company disclosed an FDA warning regarding issues with electronic data capture and a dosing error in the study, leading to a further 26% drop in stock price over three trading sessions [5] Lead Plaintiff Process - Investors who purchased or acquired Applied Therapeutics securities during the Class Period can seek appointment as lead plaintiff under the Private Securities Litigation Reform Act of 1995 [6] - The lead plaintiff represents all class members and selects the law firm to litigate the case [6] - Serving as lead plaintiff is not required to share in any potential future recovery [6] About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud cases, ranked 1 in ISS Securities Class Action Services for six of the last ten years [7] - The firm has recovered $6 6 billion for investors in securities-related class action cases, including the largest recovery ever of$7 2 billion in the Enron Corp case [7]